Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged-release Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia: a Randomized Clinical Trial

NCT01431092 is registered in ClinicalTrials.gov with Lone Baandrup as lead sponsor.

NCT NCT01431092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01431092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged-release Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia: a Randomized Clinical Trial
Lead sponsor
Lone Baandrup
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
June 30, 2014
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar affective disorder, schizoaffective disorder, schizophrenia